Elevated expression of eIF4E in confined early breast cancer lesions: Possible role of hypoxia

The translation‐initiation factor eIF4E is rate‐limiting for protein synthesis, and its over‐expression results in oncogenic transformation of mammalian cells. eIF4E facilitates the synthesis of several powerful tumor angiogenic factors (FGF‐2 and VEGF) by selectively enhancing their translation. In breast carcinomas, eIF4E is commonly over‐expressed, but the pathology where this elevation is initially manifested is presently unknown. To probe whether the elevation of eIF4E marks an early stage of cancer development, we focused our research on early cancerous lesions. We have analyzed 70 invasive ductal carcinomas (IDCs), 78 ductal carcinomas in situ (DCIS), 51 benign lesions and 4 model cell lines for elevated expression of eIF4E by several different methods: Northern/Western blots, immuno‐histochemistry and in situ RT‐PCR. eIF4E expression was markedly increased in IDC and in islets of viable cells in the center of poorly vascularized DCIS, which are not easily identifiable by standard histological stains. We also show that expression of eIF4E is increased by hypoxia and, presumably, in hypoxic areas of these lesions. We propose that clonal expansion of cancer cells, permanently over‐expressing eIF4E, gives them a critical advantage to survive hypoxia and marks the transition toward the vascular phase of cancer progression. Hence, eIF4E may be useful in stratifying DCIS lesions according to their malignant stage. Int. J. Cancer 80:516–522, 1999. © 1999 Wiley‐Liss, Inc.

[1]  J. Vaidya,et al.  Diseases of the breast , 2000, British Journal of Cancer.

[2]  A. Harris,et al.  Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E. , 1998, British Journal of Cancer.

[3]  A. Gingras,et al.  The mRNA 5' cap-binding protein eIF4E and control of cell growth. , 1998, Current opinion in cell biology.

[4]  T. Hasebe,et al.  Significance of Basic Fibroblast Growth Factor and Fibroblast Growth Factor Receptor Protein Expression in the Formation of Fibrotic Focus in Invasive Ductal Carcinoma of the Breast , 1997, Japanese journal of cancer research : Gann.

[5]  Benjamin D. L. Li,et al.  Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas , 1997, Oncogene.

[6]  A. De Benedetti,et al.  Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma , 1997, Cancer.

[7]  M. Silverstein,et al.  Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies. , 1997, Surgical oncology clinics of North America.

[8]  A. Gingras,et al.  The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. , 1996, Oncogene.

[9]  M. Polymenis,et al.  An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc , 1996, Molecular and cellular biology.

[10]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[11]  A. De Benedetti,et al.  Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis , 1996, International journal of cancer.

[12]  A. De Benedetti,et al.  Overexpression of the proto‐oncogene/translation factor 4E in breast‐carcinoma cell lines , 1996, International journal of cancer.

[13]  C. Kevil,et al.  Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. , 1995, Oncogene.

[14]  G. Breier,et al.  Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells (*) , 1995, The Journal of Biological Chemistry.

[15]  A. De Benedetti,et al.  The proto‐oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas , 1995, International journal of cancer.

[16]  I. Bièche,et al.  Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[17]  B Fisher,et al.  Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.

[18]  A. Patchefsky,et al.  Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance alone , 1992, Cancer.

[19]  B. Berse,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[20]  N. Sonenberg,et al.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.

[21]  D. Wickerham,et al.  Ductal carcinoma-in-situ. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  N. Sonenberg 8 mRNA 5′ Cap-binding Protein elF4E and Control of Cell Growth , 1996 .